Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRVB | GERN | LBPH | ||
| Company | Provention Bio Inc | Geron Corp | Longboard Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.99 | 3.98 | 59.80 | ||
| High | 25.00 | 4.11 | 59.83 | ||
| Low | 24.98 | 3.96 | 59.77 | ||
| Last | 24.98 | 4.07 | 59.80 | ||
| Change | +0.75 | +0.05 | +0.03 | ||
| % Change | +3.10% | +1.24% | +0.05% | ||
| Volume | 9,124,100 | 6,849,100 | 1,289,100 | ||
| 20-Day Average Volume | 2,505,925 | 10,171,985 | 880,045 | ||
| Previous Close | 24.23 | 4.02 | 59.77 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.34 | 4.06 | 59.73 | ||
| 20-Day Raw Stochastic | 98.15% | 52.22% | 86.73% | ||
| 20-Day Relative Strength | 79.66% | 48.66% | 75.73% | ||
| Weighted Alpha | +19.60 | +39.58 | +177.32 | ||
| Today's Opinion | 100% Buy | 24% Sell | 100% Buy | ||
| Previous Opinion | 88% Buy | 40% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.21% since 04/19/23 | +11.20% since 11/15/24 | +0.18% since 11/15/24 | ||
| Low | 24.20 on 04/25/23 | 3.60 on 11/18/24 | 59.68 on 11/18/24 | ||
| High | 25.00 on 04/26/23 | 4.11 on 11/22/24 | 59.85 on 11/19/24 | ||
| 1-Month | |||||
| %Chg | +4.56% since 03/24/23 | +1.50% since 10/22/24 | +0.67% since 10/22/24 | ||
| Low | 23.82 on 03/27/23 | 3.60 on 11/18/24 | 58.82 on 11/04/24 | ||
| High | 25.00 on 04/26/23 | 4.50 on 11/07/24 | 59.95 on 11/01/24 | ||
| 3-Month | |||||
| %Chg | +186.80% since 01/26/23 | -9.15% since 08/22/24 | +70.42% since 08/22/24 | ||
| Low | 6.59 on 03/10/23 | 3.60 on 11/18/24 | 27.35 on 09/17/24 | ||
| High | 25.00 on 04/26/23 | 4.82 on 09/20/24 | 59.95 on 11/01/24 | ||
| 6-Month | |||||
| %Chg | +279.64% since 10/26/22 | +11.20% since 05/22/24 | +203.09% since 05/22/24 | ||
| Low | 6.38 on 10/28/22 | 3.23 on 05/30/24 | 15.64 on 06/10/24 | ||
| High | 25.00 on 04/26/23 | 5.34 on 06/12/24 | 59.95 on 11/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,367,629 | 2,430,094 | 2,333,780 | ||
| Shares Outstanding, K | 94,781 | 604,501 | 39,046 | ||
| Annual Sales | 12,900,000 | 240,000 | 0 | ||
| Annual Net Income | -113,570,000 | -184,130,000 | -54,420,000 | ||
| Last Quarter Sales | 10,810,000 | 28,270,000 | 0 | ||
| Last Quarter Net Income | -33,280,000 | -26,450,000 | -24,540,000 | ||
| 60-Month Beta | 2.47 | 0.52 | 1.07 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 03/29/23 | -0.04 on 11/07/24 | -0.63 on 11/07/24 | ||
| Latest Earnings Date | 05/04/23 | 11/07/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||